Clinical Trial Update: Treatment With Quetiapine for Youth With Substance Use Disorders and Severe Mood Dysregulation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating quetiapine for youth with substance use disorders and severe mood dysregulation has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Mood Disorders
• Substance Use Disorders

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: Boston Medical Center | Conditions: Substance Use Disorders, Bipolar Disorder | Phase 4 | Status: COMPLETED | Results posted: 2022-04-18